Description

Adipotide 5mg × 10 vials

A synthetic peptidomimetic compound studied for adipose-tissue research, fat-cell vascular targeting, obesity-related models, body-composition research, metabolic regulation, apoptosis-related pathways, and broader weight-management research protocols.

Product Overview

Compound: Adipotide / FTPP
Strength: 5 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 5 mg
BAC water: 2 mL
Amount per unit: 25 mcg per unit

Research Dose

Protocol dependent.

Notes

Adipotide, also known as FTPP, is described as a synthetic peptidomimetic compound studied for its ability to target blood vessels associated with white adipose tissue in research models.

Research literature has examined Adipotide in relation to adipose-tissue vascular targeting, programmed cell-death pathways, fat-mass reduction models, insulin-sensitivity research, obesity-related mechanisms, and broader metabolic-disease pathways.

Adipotide is not a standard lipolytic peptide and should not be treated as a general fat-loss or consumer weight-management product.

Most available evidence comes from laboratory and animal research, including obesity-related preclinical models. No standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.